Current issues in Hereditary Angioedema (HAE) - Ipopi
Current issues in Hereditary Angioedema (HAE) - Ipopi
Current issues in Hereditary Angioedema (HAE) - Ipopi
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Self adm<strong>in</strong>istration<br />
C1 ınhıbıtor or ıcatıbant<br />
• Access to acute treatment (via<br />
self adm<strong>in</strong>)<br />
– estimate ~95% attacks treated<br />
– Freedom from symptoms<br />
achievable<br />
– ‘political’ difficulties<br />
• No rapid access to acute<br />
treatment<br />
– Estimate ~ 5-25% attacks<br />
treated<br />
– Acceptance<br />
– unpredictable reversible<br />
disability<br />
– Loss of opportunity<br />
– ‘Blight’ on life
Change language